Wong C L, Roberts M B, Wai M K
Eur J Pharmacol. 1980 Mar 21;62(2-3):219-23. doi: 10.1016/0014-2999(80)90280-0.
Pretreatment with phenobarbitone (5.0-20.0 mg/kg, s.c.) did not alter the antinociceptive effect (tail-flick assay) of morphine measured 4.5 h later. However, naloxone was more potent in antagonising this antinociceptive effect in phenobarbitone-pretreated mice than in saline-retreated animals. Concomitant administration of naloxone in the pretreatment regime did not alter the effect of phenobarbitone. The enhanced naloxone potency was related to the amount of phenobarbitone given, and was observable at 3.0 and 4.5 h after pretreatment. It was no longer apparent at 6.0 h. Because of a difference in time course and in the ability of naloxone to block the phenomenon, it is suggested that the mechanisms underlying the increase in naloxone potency induced by phenobarbitone pretreatment and morphine pretreatment may not be the same.
预先皮下注射苯巴比妥(5.0 - 20.0毫克/千克)不会改变4.5小时后测得的吗啡的抗伤害感受作用(甩尾试验)。然而,与生理盐水处理的动物相比,纳洛酮在拮抗苯巴比妥预处理小鼠的这种抗伤害感受作用方面更有效。在预处理方案中同时给予纳洛酮不会改变苯巴比妥的作用。纳洛酮效力增强与给予的苯巴比妥量有关,并且在预处理后3.0和4.5小时可观察到,在6.0小时时不再明显。由于时间进程以及纳洛酮阻断该现象的能力存在差异,提示苯巴比妥预处理和吗啡预处理诱导纳洛酮效力增加的潜在机制可能不同。